发明名称 |
C-terminal modification of polypeptides |
摘要 |
The invention relates to a mutated trypsin comprising an amino acid substitution both at position K60 and D189, and at least one more amino acid substitution by histidine at position N143 or position E151. Such trypsin mutant has a preferred cleavage site comprising the amino acids Xaa1-Xaa2-His, wherein Xaa1 is L, Y or F and Xaa2 is R or K. The invention also relates to a man-made polypeptide comprising a target peptide and the above cleavage site as well as to a method of producing C-terminally modified target peptides by using this mutated trypsin. |
申请公布号 |
US8927230(B2) |
申请公布日期 |
2015.01.06 |
申请号 |
US201313741206 |
申请日期 |
2013.01.14 |
申请人 |
EUCODIS Bioscience GmbH |
发明人 |
Hoess Eva;Bordusa Frank;Hermann Rupert;Jakubke Hans-Dieter;Tischer Wilhelm |
分类号 |
C12P21/06;C12N9/64;C12N9/76 |
主分类号 |
C12P21/06 |
代理机构 |
Loza & Loza, LLP |
代理人 |
Fedrick Michael;Loza & Loza, LLP |
主权项 |
1. A method of producing a C-terminally transacylated target peptide comprising the steps of:
providing a polypeptide comprising a target peptide and a restriction site peptide, wherein the restriction site peptide comprises the cleavage site Xaa1-Xaa2-His, wherein Xaa1 is L, Y or F, and Xaa2 is R or K, and wherein said restriction site peptide overlaps with the target peptide by the amino acid Xaa1 at the C-terminal end of said target peptide, bringing said polypeptide into contact with a trypsin mutant according to SEQ ID NO:1 or a trypsin mutant having at least 95% identity to SEQ ID NO:1 under conditions allowing for endoproteolytic cleavage after Xaa1, thereby forming an endoprotease target peptide-acyl-intermediate, adding an appropriate nucleophile, and, upon nucleophilic attack and binding of said nucleophile to the C-terminus of the target peptide, releasing the mutated trypsin from the endoprotease target peptide-acyl-intermediate. |
地址 |
Vienna AT |